Metabolomic linkage reveals functional interaction between glucose-dependent insulinotropic polypeptide and ghrelin in humans

American Journal of Physiology - Endocrinology and Metabolism

Volumn 301, Issue 4, 2011, Pages

  Rudovich, Natalia N ^a,b   Nikiforova, Victoria J ^c   Otto, Baerbel ^d   Pivovarova, Olga ^a,b   Gögebakan, Özlem ^a,b   Erban, Alexander ^c   Möhlig, Matthias ^a,b   Weickert, Martin O ^a,b,f   Spranger, Joachim ^b   Tschöp, Matthias H ^g   Willmitzer, Lothar ^c   Nauck, Michael ^e   Pfeiffer, Andreas F H ^a,b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR PLANT PHYSIOLOGY   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e Diabetes Centre Bad Lauterberg   (Germany)

^f UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Euglycemic hyperinsulinemic clamp; Hyperglycemic hyperinsulinemic clamp; Obesity; Time of flight gas chromatography mass spectrometry analysis

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCOSE; INSULIN; LONG CHAIN FATTY ACID; PLACEBO; SODIUM CHLORIDE; THREONINE; VALINE;

ADULT; ARTICLE; CLINICAL ARTICLE; ENERGY METABOLISM; GLUCOSE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PROTEIN MODIFICATION;

ADULT; BLOOD GLUCOSE; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; METABOLOMICS; MIDDLE AGED; OVERWEIGHT;

EID: 80053252842     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00154.2011     Document Type: Article

References (50)

1. Aguilera A, Cirugeda A, Amair R, Sansone G, Alegre L, Codoceo R, Bajo MA, del Peso G, Díez JJ, Sánchez-Tomero JA, Selgas R. Ghrelin plasma levels and appetite in peritoneal dialysis patients. Adv Perit Dial 20: 194-199, 2004.
2. Anderwald C, Brabant G, Bernroider E, Horn R, Brehm A, Waldhäusl W, Roden M. Insulin-dependent modulation of plasma ghrelin and leptin concentrations is less pronounced in type 2 diabetic patients. Diabetes 52: 1792-1798, 2003.
3. Asmar M, Simonsen L, Madsbad S, Stallknecht B, Holst JJ, Bülow J. Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans. Diabetes 59: 2160-2163, 2010.
4. Asmar M, Tangaa W, Madsbad S, Hare K, Astrup A, Flint A, Bülow J, Holst JJ. On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans. Am J Physiol Endocrinol Metab 298: E614-E621, 2010.
5. Barabási AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113, 2004.
6. Blom WA, Lluch A, Vinoy S, Stafleu A, van den Berg R, Holst JJ, Kok FJ, Hendriks HF. Effects of gastric emptying on the postprandial ghrelin response. Am J Physiol Endocrinol Metab 290: E389-E395, 2006.
7. Caixas A, Bashore C, Nash W, Pi-Sunyer FX, Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab 87: 1902-1906, 2002.
8. de la Cour CD, Norlén P, Håkanson R. Secretion of ghrelin from rat stomach ghrelin cells in response to local microinfusion of candidate messenger compounds: a microdialysis study. Regul Pept 143: 118-126, 2007.
9. Cukier K, Pilichiewicz AN, Chaikomin R, Brennan IM, Wishart JM, Rayner CK, Jones KL, Horowitz M, Feinle-Bisset C. Effect of small intestinal glucose load on plasma ghrelin in healthy men. Am J Physiol Regul Integr Comp Physiol 295: R459-R462, 2008.
10. Daousi C, Wilding JP, Aditya S, Durham BH, Cleator J, Pinkney JH, Ranganath LR. Effects of peripheral administration of synthetic human glucose-dependent insulinotropic peptide (GIP) on energy expenditure and subjective appetite sensations in healthy normal weight subjects and obese patients with type 2 diabetes. Clin Endocrinol (Oxf) 71: 195-201, 2009.
11. Expert Committee on the Diagnosis, and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20: 1183-1197, 1997.
12. Erban A, Schauer N, Fernie AR, Kopka J. Non-supervised construction and application of mass spectral and retention time index libraries from time-of-flight gas chromatography-mass spectrometry metabolite profiles. Methods Mol Biol 358: 19-38, 2007.
13. Fajans SS, Floyd JC Jr, Thiffault CA, Knopf RF, Harrison TS, Conn JW. Further studies on diazoxide suppression of insulin release from abnormal and normal islet tissue in man. Ann NY Acad Sci 50: 261-280, 1968.
14. Flanagan DE, Evans ML, Monsod TP, Rife F, Heptulla RA, Tamborlane WV, Sherwin RS. The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab 284: E313-E316, 2003.
15. Flatt PR. Dorothy Hodgkin Lecture 2008. Gastric inhibitory polypeptide (GIP) reviesed: a new therapeutic target for obesity-diabetes? Diabet Med 25: 759-764, 2008.
16. De Fronzo RA, Tobin JD, Anders R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979.
17. Gormsen LC, Gjedsted J, Gjedde S, Vestergaard ET, Christiansen JS, Jørgensen JO, Nielsen S, Møller N. Free fatty acids decrease circulating ghrelin concentrations in humans. Eur J Endocrinol 154: 667-673, 2006.
18. Gormsen LC, Nielsen C, Gjedsted J, Gjedde S, Vestergaard ET, Christiansen JS, Jørgensen JO, Møller N. Effects of free fatty acids, growth hormone and growth hormone receptor blockade on serum ghrelin levels in humans. Clin Endocrinol (Oxf) 66: 641-645, 2007.
19. Hu Z, Cha SH, van Haasteren G, Wang J, Lane MD. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects. Proc Natl Acad Sci USA 15;102: 3972-3977, 2005.
20. Jiye A, Trygg J, Gullberg J, Johansson AI, Jonsson P, Antti H, Marklund SL, Moritz X. Extraction and GC/MS analysis of the human blood plasma metabolome. Anal Chem 77: 8086-8094, 2005.
21. Kieffer TJ. GIP or not GIP? That is the question. Trends Pharmacol Sci 24: 110-112, 2003.
22. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 85: 495-522, 2005.
23. Kwasowski P, Flatt PR, Bailey CJ, Marks V. Effects of fatty acid chain length and saturation on gastric inhibitory polypeptide release in obese hyperglycaemic (ob/ob) mice. Biosci Rep 5: 701-705, 1985.
24. McLaughlin T, Abbasi F, Lamendola C, Frayo RS, Cummings DE. Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls. J Clin Endocrinol Metab 89: 1630-1635, 2004.
25. Lavin JH, Wittert GA, Andrews J, Yeap B, Wishart JM, Morris HA, Morley JE, Horowitz M, Read NW. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate. Am J Clin Nutr 68: 591-598, 1998.
26. Leonetti F, Iacobellis G, Ribaudo MC, Zappaterreno A, Tiberti C, Iannucci CV, Vecci E, Di Mario U. Acute insulin infusion decreases plasma ghrelin levels in uncomplicated obesity. Regul Pept 15;122: 179-183, 2004.
27. Lippl F, Kircher F, Erdmann J, Allescher HD, Schusdziarra V. Effect of GIP, GLP-1, insulin and gastrin on ghrelin release in the isolated rat stomach. Regul Pept 15;119: 93-98, 2004.
28. Lisec J, Schauer N, Kopka J, Willmitzer L, Fernie AR. Gas chromatography mass spectrometry based metabolite profiling in plants. Nat Protocols 1: 387-396, 2006.
29. Luedemann A, Strassburg K, Erban A, Kopka J. TagFinder for the quantitative analysis of gas chromatography-mass spectrometry (GC-MS)-based metabolite profiling experiments. Bioinformatics: 24: 732-737, 2008.
30. Meier JJ, Nauck MA, Kranz D, Holst JJ, Deacon CF, Gaeckler D, Schmidt WE, Gallwitz B. Secretion, degradation, and elimination of glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP) in patients with chronic renal insufficiency and healthy controls. Diabetes 53: 654-662, 2004.
31. Mohlig M, Spranger J, Otto B, Ristow M, Tschop M, Pfeiffer AFH. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 25: RC36-RC38, 2002.
32. Nikiforova VJ, Daub CO, Hesse H, Willmitzer L, Hoefgen R. Integrative gene-metabolite network with implemented causality deciphers informational fluxes of sulfur stress response. J Exp Bot 56: 1887-1896, 2005.
33. Nishi Y, Hiejima H, Hosoda H, Kaiya H, Mori K, Fukue Y, Yanase T, Nawata H, Kangawa K, Kojima M. Ingested medium-chain fatty acids are directly utilized for the acyl modification of ghrelin. Endocrinology 146: 2255-2264, 2005.
34. Otto B, Cuntz U, Fruehauf E, Wawarta R, Folwaczny C, Riepl RL, Heiman ML, Lehnert P, Fichter M, Tschop M. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol 145: 669-673, 2001.
35. Overduin J, Frayo RS, Grill HJ, Kaplan JM, Cummings DE. Role of the duodenum and macronutrient type in ghrelin regulation. Endocrinology 146: 845-850, 2005.
36. Parker BA, Doran S, Wishart J, Horowitz M, Chapman IM. Effects of small intestinal and gastric glucose administration on the suppression of plasma ghrelin concentrations in healthy older men and women. Clin Endocrinol (Oxf) 62: 539-546, 2005.
37. Parker HE, Habib AM, Rogers GJ, Gribble FM, Reimann F. Nutrientdependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells. Diabetologia 52: 289-298, 2009.
38. Rudovich NN, Dick D, Moehlig M, Otto B, Spranger J, Rochlitz HJ, Ristow M, Tschoep M, Pfeiffer AF. Ghrelin is not suppressed in hyperglycemic clamps by gastric inhibitory polypeptide and arginine. Regul Pept 127: 95-99, 2005.
39. Rudovich N, Kaiser S, Engeli S, Osterhoff M, Gogebakan O, Bluher M, Pfeiffer AF. GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women. Regul Pept 142: 138-145, 2007.
40. Saad MF, Bernaba B, Hwu CM, Jinagouda S, Fahmi S, Kogosov E, Boyadjian R. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab 87: 3997-4000, 2002.
41. Schaller G, Schmidt A, Pleiner J, Woloszczuk W, Wolzt M, Luger A. Plasma ghrelin concentrations are not regulated by glucose or insulin. Diabetes 52: 16-20, 2003.
42. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 404: 661-671, 2000.
43. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 407: 908-913, 2000.
44. Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R, Folwaczny C. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest 24: RC19-RC21, 2001.
45. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI. Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133: 2861-2870, 1993.
46. Verdich C, Toubro S, Buemann B, Lysgård Madsen J, Juul Holst J, Astrup A. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction. Int J Obes Relat Metab Disord 25: 1206-1214, 2001.
47. Weickert MO, Loeffelholz CV, Arafat AM, Schöfl C, Otto B, Spranger J, Möhlig M, Pfeiffer AF. Euglycemic hyperinsulinemia differentially modulates circulating total and acylated-ghrelin in humans. J Endocrinol Invest 31: 119-124, 2008.
48. Williams DL, Cummings DE, Grill HJ, Kaplan JM. Meal-related ghrelin suppression requires postgastric feedback. Endocrinology 144: 2765-2767, 2003.
49. Wisser AS, Habbel P, Wiedenmann B, Klapp BF, Mönnikes H, Kobelt P. Interactions of gastrointestinal peptides: ghrelin and its anorexigenic antagonists. Int J Pept 2010: 817457, 2010.
50. Yip RG, Wolfe MM. GIP biology and fat metabolism. Life Sci 66: 91-103, 2000.